Skin Cancer Update with Prof Giuseppe Argenziano [October 2018]

Professor Giuseppe Argenziano gives a skin cancer update in which he shares the results of recent research into methotrexate in the treatment of advanced squamous cell carcinoma.

Giuseppe discusses a variety of case studies in which methotrexate was used to treat squamous cell carcinoma in a variety of body parts and patient groups, with interesting results. He suggests that methotrexate may be viable for use in palliative settings or in circumstances where the tumour is very large.

Watch the full skin cancer update now:


To learn more from Prof Giuseppe Argenziano:

Online Certificate and Professional Diploma Program in Dermoscopy 

Led by the renowned Prof Giuseppe Argenziano and a team of 12 highly subspecialised skin cancer experts from Italy, Austria, Greece, USA, Japan, and Australia.

The three-part program will equip you with the skills to start practising dermoscopy in your practice and help you progress in your knowledge and skill to an accomplished level so you can accurately diagnose a wide range of lesions on any part of the body and skin type. Developed by members of the International Dermoscopy Society and taught by the world’s leading professors, dermatologists and researchers in their respective fields, the program can be considered the most comprehensive dermoscopy online training.

Upon completion participants will receive credit of over 50 per cent of the Master of Science with the Medical University of Graz.

You may enrol in one (Professional Certificate), two (Professional and Advanced Certificates) or all three (Professional and Advanced Certificates and Professional Diploma) courses at once. The three certificate courses build upon the knowledge of the previous course and must be completed in sequential order to qualify for the professional diploma.

hc-logo__png graz_logo           logo_ids         skin-cancer-institute_large


More skin cancer updates from Prof Giuseppe Argenziano:

Leave a Reply

Your email address will not be published.